Radiation: A New Multi-Disciplinary Open Access Journal for Advances in Radiation Technology
Conflicts of Interest
References
- Radiation. Available online: https://www.mdpi.com/journal/radiation (accessed on 10 May 2020).
- Stangl, S.; Tontcheva, N.; Sievert, W.; Shevtsov, M.; Niu, M.; Schmid, T.E.; Pigorsch, S.; Combs, S.E.; Haller, B.; Balermpas, P.; et al. Heat shock protein 70 expression and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck (SCCHN) after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology (DKTK-ROG). Int. J. Can. 2018, 142, 1911–1925. [Google Scholar]
- Tzoumas, S.; Nunes, A.; Olefir, I.; Stangl, S.; Symvoulidis, P.; Glasl, S.; Bayer, C.; Multhoff, G.; Ntziachristos, V. Eigenspectra optoacoustic tomography achieves quantitative blood oxygenation imaging deep in tissues. Nat. Commun. 2016, 7. [Google Scholar] [CrossRef] [PubMed]
- Shevtsov, M.; Stangl, S.; Nikolaev, B.; Yakovleva, L.; Marchenko, Y.; Tagaeva, R.; Sievert, W.; Pitkin, E.; Mazur, A.; Tolstoy, P.; et al. Granzyme B functionalized nanoparticles targeting membrane Hsp70-positive tumors for multimodal cancer theranostics. Small 2019, 15, e1900205. [Google Scholar] [CrossRef] [PubMed]
- Multhoff, G.; Seier, S.; Stangl, S.; Sievert, W.; Shevtsov, M.; Werner, C.; Pockley, A.G.; Blankenstein, C.; Hildebrandt, M.; Offner, R.; et al. Targeted NK cell based adoptive immunotherapy for the treatment of patients with NSCLC after radiochemotherapy: A randomized phase II clinical trial. Clin. Can. Res. 2020, 26, 5368–5379. [Google Scholar] [CrossRef] [PubMed]
Short Biography of Author
| Gabriele Multhoff: Prof. Dr. Gabriele Multhoff is heading the Research group “Radiation Immuno-Oncology” at the Central Institute for Translational Cancer Research, Klinikum rechts der Isar, TU München (TranslaTUM). For more than 15 years, Prof. Multhoff has had a research interest in the development of innovative immunotherapies based on NK cells, antibodies, and targeting nanoparticles in combination with radiation therapy. Prof. Multhoff’s research group aims to identify tumor-specific biomarkers for multimodal tumor imaging and theranostic purposes and studies radiation-induced mechanisms in normoxic and hypoxic tumor cells. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Multhoff, G. Radiation: A New Multi-Disciplinary Open Access Journal for Advances in Radiation Technology. Radiation 2021, 1, 77-78. https://doi.org/10.3390/radiation1010007
Multhoff G. Radiation: A New Multi-Disciplinary Open Access Journal for Advances in Radiation Technology. Radiation. 2021; 1(1):77-78. https://doi.org/10.3390/radiation1010007
Chicago/Turabian StyleMulthoff, Gabriele. 2021. "Radiation: A New Multi-Disciplinary Open Access Journal for Advances in Radiation Technology" Radiation 1, no. 1: 77-78. https://doi.org/10.3390/radiation1010007
APA StyleMulthoff, G. (2021). Radiation: A New Multi-Disciplinary Open Access Journal for Advances in Radiation Technology. Radiation, 1(1), 77-78. https://doi.org/10.3390/radiation1010007